title: Impact of new hepatitis C treatments in different regions of the world.
authors.affiliation: Peking University People's Hospital and Beijing Key Laboratory for Hepatitis C and Liver Disease Immunotherapy, Beijing, China and University of Michigan Health System - Peking University Health Sciences Center Joint Institute for Clinical and Translational Research.
authors.forename: Lai
authors.initials: L
authors.lastname: Wei
authors.affiliation: University of Michigan Health System Ann Arbor, Michigan and University of Michigan Health System - Peking University Health Sciences Center Joint Institute for Clinical and Translational Research.
authors.forename: Anna S F
authors.initials: AS
authors.lastname: Lok
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003906:Developing Countries; D024882:Drug Resistance, Viral; D004359:Drug Therapy, Combination; D005838:Genotype; D014943:Global Health; D006297:Health Services Accessibility; D016174:Hepacivirus / Q000187:drug effects* / Q000235:genetics; D006526:Hepatitis C / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D018579:Patient Selection; D010641:Phenotype; D015995:Prevalence; D059039:Standard of Care; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents